PMV Pharmaceuticals, Inc. Research And Development Expense

Quick Answer

PMV Pharmaceuticals, Inc. reported Research And Development Expense of $69.88 million for the year ending 2025.

  • PMV Pharmaceuticals, Inc. showed an increase of +19.4% in Research And Development Expense from 2024 to 2025.
  • This data is from PMV Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on March 6, 2026.
  • XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 8 years of available data (2018 to 2025), PMV Pharmaceuticals, Inc.'s Research And Development Expense has grown by 404.4%.
  • Historical annual values: Fiscal year 2025: $69.88 million | Fiscal year 2024: $58.53 million | Fiscal year 2023: $55.89 million | Fiscal year 2022: $51.99 million | Fiscal year 2021: $36.49 million | Fiscal year 2020: $23.93 million | Fiscal year 2019: $20.76 million | Fiscal year 2018: $13.85 million.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: